Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
immunosuppressant |
| gptkbp:administeredBy |
subcutaneous injection
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
gptkb:L04AC14
|
| gptkbp:brand |
gptkb:Kevzara
|
| gptkbp:CASNumber |
1189541-62-1
|
| gptkbp:developedBy |
gptkb:Sanofi
gptkb:Regeneron_Pharmaceuticals |
| gptkbp:hasMolecularFormula |
C6428H9954N1714O2016S46
|
| https://www.w3.org/2000/01/rdf-schema#label |
sarilumab
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
IL-6 receptor antagonist
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:sideEffect |
neutropenia
injection site reactions increased liver enzymes |
| gptkbp:target |
gptkb:interleukin-6_receptor
|
| gptkbp:usedFor |
rheumatoid arthritis
|
| gptkbp:bfsParent |
gptkb:interleukin-6
gptkb:human_interleukin-6 gptkb:Kevzara |
| gptkbp:bfsLayer |
6
|